semaglutide covered by medi cal 🚨 California Alert: Coverage for Obesity Medications at Risk Just two years after Medi-Cal began covering FDA-approved GLP-1 medications for obesity, that coverage is set to end in January 2026 — a States Are Walking Back Medicaid

Ratan RR

Serum indoxyl sulfate associates with postangioplasty thrombosis of dialysis grafts

You have to provide them access to a registered dietitian, you have to provide them access to a gym membership, you have to provide them access to a fitness instructor or whatever network of services it is that you can provide to make sure that the change is in a lifestyle and not just in taking a medication once a week, he said

Zepbound and other GLP-1 receptor agonists have transformed weight loss for millions, but rapid fat loss can trigger gallstone development in approximately 1025% of people undergoing significant weight reduction

Interest in providing the coverage appears to be waning, the survey found, probably because of the drugs cost and other state budget pressures